Determinants of heterosexual men's demand for long-acting injectable pre-exposure prophylaxis (PrEP) for HIV in urban South Africa

被引:18
|
作者
Cheng, Chih-Yuan [1 ,2 ,3 ]
Quaife, Matthew [1 ]
Eakle, Robyn [4 ]
Escobar, Maria A. Cabrera [4 ]
Vickerman, Peter [5 ]
Terris-Prestholt, Fern [1 ]
机构
[1] London Sch Hyg & Trop Med, Fac Publ Hlth & Policy, 15-17 Tavistock Pl, London WC1H 9SH, England
[2] Heidelberg Univ, Med Fac Mannheim, Theodor Kutzer Ufer 1-3, D-68167 Mannheim, Germany
[3] German Canc Res Ctr, Div Hlth Econ, Neuenheimer Feld 280, D-69120 Heidelberg, Germany
[4] Univ Witwatersrand, Wits RHI, 22 Esselen St, ZA-2001 Johannesburg, South Africa
[5] Univ Bristol, Sch Social & Community Med, Canynge Hall,39 Whatley Rd, Bristol BS8 2PS, Avon, England
基金
英国经济与社会研究理事会;
关键词
HIV prevention; Long-acting injectable pre-exposure prophylaxis; Heterosexual men; South Africa; Biomedical strategies; ANTIRETROVIRAL PROPHYLAXIS; PREVENTION; INFECTION; SEX; RISK; PREFERENCES; TRANSMISSION; WILLINGNESS; PERCEPTIONS; TENOFOVIR;
D O I
10.1186/s12889-019-7276-1
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
BackgroundHeterosexual men in South Africa are a large key population to exposure to HIV, yet preferences for HIV pre-exposure prophylaxis (PrEP) among this population have not, to date, been investigated in the literature. This paper aims to explore HIV prevention preferences among heterosexual men in urban South Africa, as well as to examine the demand and characteristics of men who favour long-acting injectable (LAI) PrEP over condoms and oral PrEP.MethodsData were collected among 178 self-reported HIV-negative heterosexual men, who were given example products and information before being asked which they preferred. Multivariate logistic regression was used to analyse which characteristics were associated with product choice.Results48% (n=85) of participants preferred LAI PrEP, while 33% (n=58) and 20% (n=35) chose oral PrEP and condoms respectively. Having children (marginal effect=0.22; 95% CI [0.01, 0.44]) or having higher risk attitude scores (marginal effect=0.03; 95% CI [0.01, 0.06]) was significantly associated with a choice of LAI PrEP, while those who had unprotected anal intercourse (marginal effect=-0.42; 95% CI [-0.57, -0.27]) and those who were concerned with protection against other sexually transmitted infections over HIV (marginal effect=-0.42; 95% CI [-0.60, -0.24]) appeared less likely to prefer LAI PrEP.ConclusionsThe results suggested a relatively high demand and theoretical acceptability for LAI PrEP among heterosexual men in urban South Africa, but there appeared to be fewer distinct predictors for the willingness to use LAI PrEP compared to studies conducted among gay and bisexual men and women. Nevertheless, the findings contribute to the mapping of the demand and determinants of heterosexual men's preferences for novel antiretroviral-based prevention in sub-Saharan Africa, and the data could aid in the differentiated design of future HIV prevention strategies using LAI PrEP in conjunction with other methods.
引用
收藏
页数:9
相关论文
共 50 条
  • [21] Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study
    van Vliet, Marjolein M.
    Hendrickson, Cheryl
    Nichols, Brooke E.
    Boucher, Charles A. B.
    Peters, Remco P. H.
    van de Vijver, David A. M. C.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2019, 22 (12)
  • [22] Pharmacogenomics of drug transporters for antiretroviral long-acting pre-exposure prophylaxis for HIV
    Zondo, Nomusa M.
    Sobia, Parveen
    Sivro, Aida
    Ngcapu, Sinaye
    Ramsuran, Veron
    Archary, Derseree
    FRONTIERS IN GENETICS, 2022, 13
  • [23] Cabotegravir-Global Access to Long-Acting Pre-exposure Prophylaxis for HIV
    Pepperrell, Toby
    Cross, Samuel
    Hill, Andrew
    OPEN FORUM INFECTIOUS DISEASES, 2023, 10 (01):
  • [24] Willingness of community-recruited men who have sex with men in Washington, DC to use long-acting injectable HIV pre-exposure prophylaxis
    Levy, Matthew E.
    Patrick, Rudy
    Gamble, Jonjelyn
    Rawls, Anthony
    Opoku, Jenevieve
    Magnus, Manya
    Kharfen, Michael
    Greenberg, Alan E.
    Kuo, Irene
    PLOS ONE, 2017, 12 (08):
  • [25] Attribute Preferences for Long-acting Pre-exposure Prophylaxis (PrEP): Results of a Discrete Choice Experiment With South African Youth
    Minnis, Alexandra
    Atujuna, Millicent
    Browne, Erica
    Ndwayana, Sheily
    Hartmann, Miriam
    Sindelo, Siyaxolisa
    Ngcwayi, Nangamso
    Boeri, Marco
    Mansfield, Carol
    Bekker, Linda-Gail
    Montgomery, Elizabeth
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2018, 34 : 27 - 27
  • [26] M Long-Acting Injectable Preexposure Prophylaxis for HIV Prevention in South Africa: Is There a Will and a Way?
    Landovitz, Raphael J.
    Grinsztejn, Beatriz
    JOURNAL OF INFECTIOUS DISEASES, 2016, 213 (10): : 1519 - 1520
  • [27] Exploring preferences and decision-making about long-acting injectable HIV pre-exposure prophylaxis (PrEP) among young sexual minority men 17–24 years old
    Steven A. John
    Juan P. Zapata
    Madeline Dang
    Benedikt Pleuhs
    Andrew O’Neil
    Sabina Hirshfield
    Jennifer L. Walsh
    Andrew E. Petroll
    Katherine G. Quinn
    Scientific Reports, 13
  • [28] High Interest in Long-acting Injectable Pre-exposure Prophylaxis (LAI-PrEP) for HIV Prevention Among Men Who Have Sex With Men (MSM): Result From A Nationwide Survey in Malaysia
    Paudel, Kiran
    Gupta, Sana
    Gautam, Kamal
    Wickersham, Jeffrey A.
    Khati, Antoine
    Azwa, Iskandar
    Ha, Toan
    Shrestha, Roman
    JOURNAL OF COMMUNITY HEALTH, 2023, 48 (03) : 513 - 521
  • [29] High Interest in Long-acting Injectable Pre-exposure Prophylaxis (LAI-PrEP) for HIV Prevention Among Men Who Have Sex With Men (MSM): Result From A Nationwide Survey in Malaysia
    Kiran Paudel
    Sana Gupta
    Kamal Gautam
    Jeffrey A Wickersham
    Antoine Khati
    Iskandar Azwa
    Toan Ha
    Roman Shrestha
    Journal of Community Health, 2023, 48 : 513 - 521
  • [30] Preferences for implementing long-acting injectable pre-exposure prophylaxis among cisgender men who have sex with men in the United States
    Beckham, S. W.
    Sanchez, T.
    Zlotorzynska, M.
    Rai, M.
    Sullivan, P.
    Hyman, S.
    Vannappagari, V.
    Sarkar, S.
    Reinhart, A.
    Rawlings, K.
    Bridges, J. F.
    JOURNAL OF THE INTERNATIONAL AIDS SOCIETY, 2021, 24 : 29 - 30